GLS1 demonstrates higher expression in solid tumors such as stomach adenocarcinoma, head and neck squamous cell carcinoma, thymoma, testicular germ cell tumors, hepatocellular carcinoma, and colon adenocarcinoma, according to the TCGA database analysis. Here, GLS is linked to hepatocellular carcinoma.